Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;329:111 (10 July), doi:10.1136/bmj.329.7457.111
| The first 150 words of the full text of this article appear below. |
EDITORThe initial statement in Ammann et al's editorial on raised cardiac troponins, "Troponin T and troponin I are highly sensitive and specific markers of myocardial injury," is contradicted by a later statement: "In sepsis, for example, cardiac troponins are raised in up to 85% of patients in the absence of any acute coronary syndromes."1
Although troponins are clearly highly sensitive for acute coronary syndromes, and therefore valuable for risk stratification in patients presenting with classic cardiac chest pain, the real issue is the specificity of troponin assays when randomly applied in general medical admissions units to patients presenting as unwell (and not necessarily with cardiac syndromes). Given a high false positive rate in non-cardiac conditionssepsis syndromes, eclampsia, and otherstheir specificity must be suspect.
Not unusually, an admitting junior doctor merrily "ticks all the boxes" on the clinical chemistry form and the patient (who clearly has pneumonia, without cardiac
Matthew L Grove, consultant rheumatologist
Tyneside General Hospital, North Shields NE29 8NH Matthew.Grove@northumbria-healthcare.nhs.uk